| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SCMH1_0011500 | Intron-Exon-Intron | chr1:41608550-41697909 | chr1:41142878-41232237 | 250 nt | 0.3320 |
| hsa_chr1_0871200 | Intergenic-Intergenic | chr1:41610462-41610933 | chr1:41144790-41145261 | 472 nt | 0.2881 |
| hsa_chr1_0871300 | Intergenic-Intergenic | chr1:41612013-41612167 | chr1:41146341-41146495 | 155 nt | 0.4000 |
| hsa_SCMH1_0012100 | Intron-Intron | chr1:41614712-41616413 | chr1:41149040-41150741 | 1702 nt | 0.4066 |
| hsa_chr1_0871400 | Intergenic-Intergenic | chr1:41615451-41616393 | chr1:41149779-41150721 | 943 nt | 0.4486 |
| hsa_chr1_0871500 | Intergenic-Intergenic | chr1:41617094-41618301 | chr1:41151422-41152629 | 294 nt | 0.4286 |
| hsa_SCMH1_0012200 | Exon-Exon | chr1:41617286-41618413 | chr1:41151614-41152741 | 214 nt | 0.4813 |
| hsa_SCMH1_0012300 | Exon-Exon | chr1:41617286-41625605 | chr1:41151614-41159933 | 423 nt | 0.4019 |
| hsa_SCMH1_0012400 | Exon-Exon | chr1:41617286-41627104 | chr1:41151614-41161432 | 373 nt | 0.3700 |
| hsa_chr1_0871600 | Intergenic-Intergenic | chr1:41619583-41620872 | chr1:41153911-41155200 | 1290 nt | 0.3357 |
A study in humans demonstrated that the circSCMH1 is significantly decreased in the plasma of patients with acute ischemic stroke and is significant in predicting stroke outcomes [Wei et al. DOI:10.1186/s12883-021-02397-0]. A study in mice demonstrated that exosomes from adipose-derived stem cells delivering the circSCMH1 reduced nerve damage by promoting microglial M2 polarization [Li et al. DOI:10.1016/j.neuint.2023.105643].